Skip to content

RCT to Evaluate Biocompatibility of Resin-based Dental Materials

Randomized Clinical Trial in Children to Evaluate the Biocompatibility of Resin-based Dental Materials

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02874625
Enrollment
200
Registered
2016-08-22
Start date
2017-08-30
Completion date
2025-11-30
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Materials Testing

Brief summary

In this randomized clinical trial, the bio-compatibility of 2 materials used for dental restorations will be compared: glass-ionomer vs resin-based composites. Urine and saliva samples will be taken for determination of bisphenol A levels at several time points, and for analysis of the estrogenic activity using ERE-CALUX. Also buccal cells will be taken. Next, DNA extraction will be done with a commercial kit. Global alterations in DNA methylation and DNA hydroxymethylation levels will be determined using UPLC-MS/MS.

Interventions

PROCEDUREDental restoration

Teeth with caries will be restored

Sponsors

KU Leuven
CollaboratorOTHER
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* one or more carious lesions in primary molars that require treatment

Exclusion criteria

* carious lesions that already affected the dental pulp, large lesions requiring cusp replacement, presence of oral inflammatory conditions during the previous 2 weeks, carriage of a fixed or removable prosthesis/orthodontic appliance, chronic disease requiring intake of drugs, exposure to diagnostic X-rays in previous 2 months, previous dental restorations

Design outcomes

Primary

MeasureTime frame
Urinary bisphenol A levels1 year
Salivary bisphenol A levels1 year
%DNA methylation6 months
%DNA hydroxymethylation6 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026